Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation

Table 1 Comparison of baseline clinicopathological parameters between transplant hepatocellular carcinoma patients with and without post-transplant infection

Clinicopathological parameter	Total (n = 238)	PTI group (n = 53)	Non-PTI group (n = 185)	P-value
Age, median (range), yr	49.5 (43, 55)	49 (43.5, 55.5)	50 (44, 55)	0.962
Sex (male/female)	209/29	44/9	165/20	0.226
Liver cirrhosis (yes/no)	214/24	46/7	168/17	0.392
Pre-operative AFP level (≥ 200 ng/mL/< 200 ng/mL)1	96/137	20/31	76/106	0.744
Child-Pugh Score (A/B/C)	128/84/26	26/18/9	102/66/17	0.272
HBsAg (positive/negative)	214/24	48/5	166/19	0.895
HBeAg (positive/negative)	68/170	15/38	53/132	0.961
Tumor number (single/multiple)	135/103	32/21	103/82	0.613
Tumor size (≤ 5 cm/> 5 cm)	169/69	41/12	128/57	0.248
Histological grade (G1-G2/G3-G4)1	190/30	46/4	144/26	0.186
Vascular invasion (yes/no)1	105/92	26/22	79/70	0.890
Lymph node involvement (yes/no)	10/228	2/51	8/177	1.000
Pathological TNM stage (I-II/III)	197/41	43/10	154/31	0.720

¹The number of cases was less than the total patient number (n = 238) because of missing data. PTI: Post-transplant infection; AFP: Alpha fetoprotein.